Viewing Study NCT03160794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT03160794
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2017-05-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
Sponsor: University Health Network, Toronto
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 16-5532
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators